First human test: stem cells target brittle bones
NCT ID NCT06949137
Summary
This early-stage study is testing the safety of a single injection of human stem cells in postmenopausal women with severe osteoporosis who are at high risk of bone fractures. The main goal is to see if the treatment is safe and well-tolerated, not to prove it works. Researchers will monitor 9 participants closely for side effects and track how the body processes the cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPOROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
HELP Therapeutics
Nanjing, Jiangsu, 210000, China
Conditions
Explore the condition pages connected to this study.